An exploration of the AI corporations in healthcare, the drug worth debate and the newest twist within the Trump Administration’s allegation that Tylenol is linked to autism had been the recent subjects on the newest episode of the Debunked Podcast hosted by Arundhati Parmar, editor in chief of MedCity Information, and Samir Batra, managing accomplice of Well being Innovation Pitch.
A part of the dialog centered on TrumpRx, a platform the Trump administration introduced this summer time that’s designed to scale back drug costs for People. To this point, two drug makers have dedicated to help TrumpRx. Pfizer was the primary and printed an announcement on the finish of September.
“Pfizer has voluntarily agreed to implement measures designed to make sure People obtain comparable drug costs to these accessible in different developed international locations and pricing newly launched medicines at parity with different key developed markets,” the announcement learn. “Pfizer will even take part in a direct buying platform, TrumpRx.gov, that may permit American sufferers to buy medicines from Pfizer at a major low cost. The big majority of the corporate’s main care remedies and a few choose specialty manufacturers shall be supplied at financial savings that may vary as excessive as 85% and on common 50%,” based on its press launch. One caveat: “particular phrases of the settlement stay confidential”.
AstraZeneca additionally dedicated to decreasing costs on lots of its medication, in addition to supporting home manufacturing.
A lot of the dialog centered on the outlook for corporations jockeying for place within the race to undertake AI in healthcare. Ambient AI and Abridge are main gamers which have raised hundreds of thousands to advance and develop their AI software program functions. Nabla has grabbed consideration for streamlining scientific documentation for digital well being information (EHRs). Nvidia is working with Eli Lilly on utilizing AI to establish drug growth targets and different functions. Arundhati and Samir additionally supplied their outlook on AI. Samir stated he expects loads of consolidation throughout the sector within the subsequent 12-18 months. He stated he expects 70% of the smaller AI companies, together with startups, to both be absorbed by the bigger gamers by means of M&A offers or fade away.
The dialog additionally touched on HHS and the drama over HHS Secretary Robert F Kennedy Jr’s allegations tying the energetic ingredient in Tylenol, acetaminophen, to autism earlier than clarifying he has no ample proof of a causal hyperlink. Texas Legal professional Basic Ken Paxton just lately filed a lawsuit in opposition to Johnson & Johnson, which owns the Tylenol model.
Watch the total episode:
